vs
Side-by-side financial comparison of PagerDuty, Inc. (PD) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $124.5M, roughly 1.3× PagerDuty, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs -82.0%, a 211.7% gap on every dollar of revenue. On growth, PagerDuty, Inc. posted the faster year-over-year revenue change (4.7% vs -22.7%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $-36.6M). Over the past eight quarters, PagerDuty, Inc.'s revenue compounded faster (5.9% CAGR vs -11.5%).
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
PD vs PTCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $124.5M | $164.7M |
| Net Profit | $161.6M | $-135.0M |
| Gross Margin | 85.3% | — |
| Operating Margin | 6.5% | -43.3% |
| Net Margin | 129.7% | -82.0% |
| Revenue YoY | 4.7% | -22.7% |
| Net Profit YoY | 2827.7% | -104.8% |
| EPS (diluted) | $1.69 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $124.5M | $164.7M | ||
| Q3 25 | $123.4M | $211.0M | ||
| Q2 25 | $119.8M | $178.9M | ||
| Q1 25 | $121.4M | $1.2B | ||
| Q4 24 | $118.9M | $213.2M | ||
| Q3 24 | $115.9M | $196.8M | ||
| Q2 24 | $111.2M | $186.7M | ||
| Q1 24 | $111.1M | $210.1M |
| Q4 25 | $161.6M | $-135.0M | ||
| Q3 25 | $9.6M | $15.9M | ||
| Q2 25 | $-7.2M | $-64.8M | ||
| Q1 25 | $-8.8M | $866.6M | ||
| Q4 24 | $-5.9M | $-65.9M | ||
| Q3 24 | $-10.9M | $-106.7M | ||
| Q2 24 | $-17.1M | $-99.2M | ||
| Q1 24 | $-28.2M | $-91.6M |
| Q4 25 | 85.3% | — | ||
| Q3 25 | 84.6% | — | ||
| Q2 25 | 84.0% | — | ||
| Q1 25 | 83.6% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 82.7% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.7% | — |
| Q4 25 | 6.5% | -43.3% | ||
| Q3 25 | 2.9% | 1.4% | ||
| Q2 25 | -8.6% | -19.5% | ||
| Q1 25 | -9.6% | 82.5% | ||
| Q4 24 | -8.7% | -76.2% | ||
| Q3 24 | -13.8% | -27.7% | ||
| Q2 24 | -19.5% | -21.5% | ||
| Q1 24 | -30.1% | -21.6% |
| Q4 25 | 129.7% | -82.0% | ||
| Q3 25 | 7.8% | 7.5% | ||
| Q2 25 | -6.0% | -36.3% | ||
| Q1 25 | -7.2% | 73.7% | ||
| Q4 24 | -5.0% | -30.9% | ||
| Q3 24 | -9.4% | -54.2% | ||
| Q2 24 | -15.4% | -53.1% | ||
| Q1 24 | -25.3% | -43.6% |
| Q4 25 | $1.69 | $-1.63 | ||
| Q3 25 | $0.10 | $0.20 | ||
| Q2 25 | $-0.07 | $-0.83 | ||
| Q1 25 | $-0.12 | $10.04 | ||
| Q4 24 | $-0.07 | $-0.85 | ||
| Q3 24 | $-0.14 | $-1.39 | ||
| Q2 24 | $-0.26 | $-1.29 | ||
| Q1 24 | $-0.34 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $547.8M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $320.5M | $-205.3M |
| Total Assets | $1.0B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $547.8M | $1.9B | ||
| Q3 25 | $567.9M | $1.7B | ||
| Q2 25 | $597.1M | $2.0B | ||
| Q1 25 | $570.8M | $2.0B | ||
| Q4 24 | $542.2M | $1.1B | ||
| Q3 24 | $599.3M | $1.0B | ||
| Q2 24 | $592.8M | $1.1B | ||
| Q1 24 | $571.2M | $884.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $484.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $489.5M | — |
| Q4 25 | $320.5M | $-205.3M | ||
| Q3 25 | $180.7M | $-155.8M | ||
| Q2 25 | $145.7M | $-206.5M | ||
| Q1 25 | $129.8M | $-185.8M | ||
| Q4 24 | $111.6M | $-1.1B | ||
| Q3 24 | $164.7M | $-1.1B | ||
| Q2 24 | $174.0M | $-980.2M | ||
| Q1 24 | $171.6M | $-893.9M |
| Q4 25 | $1.0B | $2.9B | ||
| Q3 25 | $891.5M | $2.6B | ||
| Q2 25 | $926.8M | $2.6B | ||
| Q1 25 | $927.3M | $2.7B | ||
| Q4 24 | $866.8M | $1.7B | ||
| Q3 24 | $916.0M | $1.8B | ||
| Q2 24 | $924.0M | $1.9B | ||
| Q1 24 | $925.3M | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.73× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.85× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.8M | $-34.3M |
| Free Cash FlowOCF − Capex | $24.1M | $-36.6M |
| FCF MarginFCF / Revenue | 19.3% | -22.3% |
| Capex IntensityCapex / Revenue | 0.6% | 1.4% |
| Cash ConversionOCF / Net Profit | 0.15× | — |
| TTM Free Cash FlowTrailing 4 quarters | $117.6M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.8M | $-34.3M | ||
| Q3 25 | $34.0M | $-66.3M | ||
| Q2 25 | $30.7M | $-58.3M | ||
| Q1 25 | $31.4M | $870.1M | ||
| Q4 24 | $22.1M | $-30.0M | ||
| Q3 24 | $35.8M | $-77.0M | ||
| Q2 24 | $28.6M | $-71.5M | ||
| Q1 24 | $22.2M | $70.8M |
| Q4 25 | $24.1M | $-36.6M | ||
| Q3 25 | $33.1M | $-69.7M | ||
| Q2 25 | $30.2M | $-59.6M | ||
| Q1 25 | $30.3M | $868.4M | ||
| Q4 24 | $21.5M | $-33.8M | ||
| Q3 24 | $35.1M | $-77.5M | ||
| Q2 24 | $28.2M | $-78.8M | ||
| Q1 24 | $21.2M | $61.2M |
| Q4 25 | 19.3% | -22.3% | ||
| Q3 25 | 26.8% | -33.1% | ||
| Q2 25 | 25.2% | -33.3% | ||
| Q1 25 | 24.9% | 73.8% | ||
| Q4 24 | 18.1% | -15.8% | ||
| Q3 24 | 30.3% | -39.4% | ||
| Q2 24 | 25.4% | -42.2% | ||
| Q1 24 | 19.1% | 29.1% |
| Q4 25 | 0.6% | 1.4% | ||
| Q3 25 | 0.7% | 1.6% | ||
| Q2 25 | 0.4% | 0.7% | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 0.5% | 1.8% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 0.4% | 4.0% | ||
| Q1 24 | 0.9% | 4.6% |
| Q4 25 | 0.15× | — | ||
| Q3 25 | 3.55× | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
PTCT
Segment breakdown not available.
